2017, Number 1
<< Back Next >>
Rev Invest Clin 2017; 69 (1)
High Dietary Magnesium Intake is Significantly and Independently Associated with Higher Insulin Sensitivity in a Mexican-Mestizo Population: A Brief Cross-Sectional Report
Moctezuma-Velázquez C, Gómez-Sámano MÁ, Cajas-Sánchez MB, Reyes-Molina DL, Galindo-Guzmán M, Meza-Arana CE, Cuevas-Ramos D, Gómez-Pérez FJ, Gulias-Herrero A
Language: English
References: 42
Page: 40-46
PDF size: 169.67 Kb.
ABSTRACT
Background: Magnesium acts as a cofactor in many intracellular reactions including phosphorylation of the insulin receptor;
therefore, its imbalance can potentially cause insulin resistance. Low serum magnesium concentration has been associated with
the development of metabolic syndrome and type 2 diabetes mellitus.
Objective: To study the association between the daily
dietary magnesium intake and insulin resistance estimated by the homeostatic model assessment of insulin resistance and
homeostatic model assessment 2, as well as insulin sensitivity estimated by the Matsuda index.
Methods: In a university affiliated
medical center, 32 participants (22 women, 10 men) that had an indication for testing for type 2 diabetes mellitus with
an oral glucose tolerance test were enrolled in this cross-sectional, comparative study. Clinical and biochemical evaluations were
carried out including an oral glucose tolerance test. Hepatic insulin resistance index, homeostatic model assessment 2, homeostatic
model assessment of insulin resistance, and Matsuda insulin sensitivity were calculated for each participant. They were
asked to recall their food ingestion (24 hours) of three days of the past week, including a weekend day; magnesium intake was
calculated according to the food nutritional information.
Results: The low dietary magnesium intake group (‹ 4.5 mg/kg/day)
had a higher two-hour insulin concentration after an oral glucose tolerance test compared to those with high dietary magnesium
(119.5 [73.0-190.6] vs. 63.5 [25.4-114.2]; p = 0.008), and insulin sensitivity assessed by the Matsuda index was higher in the
high dietary magnesium intake group (4.3 ± 3.1 vs. 2.4 ± 1.5; p = 0.042). In multiple linear regression analysis a higher dietary
magnesium intake was independently associated (β = 4.93; p = 0.05) with a better insulin sensitivity estimated by the Matsuda
index.
Conclusions: Our results suggest that higher magnesium intake is independently associated with better insulin
sensitivity in patients at risk for type 2 diabetes mellitus.
REFERENCES
International Diabetes Federation. IDF DIABETES ATLAS [Internet]. 7th ed. Brussels, Belgium; 2015. Available from: http:// www.diabetesatlas.org/
Hernández-Ávila M, Gutiérrez JP, Reynoso-Noverón N. [Diabetes mellitus in Mexico. Status of the epidemic.] Salud Publica Mex. 2013;55(Suppl 2):S129-36.
Altura BM. Basic biochemistry and physiology of magnesium: a brief review. Magnes Trace Elem. 1991-1992;10:167-71.
Topf JM, Murray PT. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord. 2003;4:195-206.
Weisinger JR, Bellorín-Font E. Magnesium and phosphorus. Lancet. 1998;352:391-6.
Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res. 2004;17:126-36.
Standing Committee On The Scientific Evaluation Of Dietary Reference Intakes-Food and Nutrition Board-Institute of Medicine, Press-National Academy. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride [Internet]. Washington, D.C.: National Academies Press; 1997. Available from: http://www.nap.edu/catalog/5776 [Accessed 2016 Sep 27].
Marier JR. Magnesium content of the food supply in the modern- day world. Magnesium. 1986;5:1-8.
Sakaguchi Y, Shoji T, Hayashi T, et al. Hypomagnesemia in type 2 diabetic nephropathy: A novel predictor of end-stage renal disease. Diabetes Care. 2012;35:1591-7.
Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med. 1999;159:2151-9.
Barbagallo M, Dominguez LJ, Galioto A, et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med. 2003;24:39-52.
Barbagallo M, Dominguez LJ, Resnick LM. Magnesium metabolism in hypertension and type 2 diabetes mellitus. Am J Ther. 2007;14:375-85.
Veronese N, Watutantrige SF, Luchini C, et al. Effect of magnesium supplementation on glucose metabolism in people with or at risk of diabetes: a systematic review and meta-analysis of double-blind randomized controlled trials. Eur J Clin Nutr. 2016; 70:1354-9.
Epstein FH, Moller DE, Flier JS. Insulin Resistance — Mechanisms, Syndromes, and Implications. N Engl J Med. 1991;325:938-48.
Guerrero-Romero F, Simental-Mendía LE, Hernández-Ronquillo G, Rodriguez-Morán M. Oral magnesium supplementation improves glycaemic status in subjects with prediabetes and hypomagnesaemia: A double-blind placebo-controlled randomized trial. Diabetes Metab. 2015;41:202-7.
Ma B, Lawson AB, Liese AD, Bell RA, Mayer-Davis EJ. Dairy, magnesium, and calcium intake in relation to insulin sensitivity: Approaches to modeling a dose-dependent association. Am J Epidemiol. 2006;164:449-58.
Larsson SC, Wolk A. Magnesium intake and risk of type 2 diabetes: A meta-analysis. J Intern Med. 2007;262:208-14.
Rodríguez-Morán M, Guerrero-Romero F. Oral magnesium supplementation improves insulin sensitivity and metabolic control in type 2 diabetic subjects - A randomized double-blind controlled trial. Diabetes Care. 2003;26:1147-52.
Guerrero-Romero F, Tamez-Perez H, González-González G, et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab. 2004;30: 253-8.
Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PWF, Jacques PF. Magnesium intake is related to improved insulin homeostasis in the Framingham offspring cohort. J Am Coll Nutr. 2006;25:486-92.
Konishi K, Wada K, Tamura T, Tsuji M, Kawachi T, Nagata C. Dietary magnesium intake and the risk of diabetes in the Japanese community: results from the Takayama study. Eur J Nutr. 2015. [Epub ahead of print].
Wang J, Persuitte G, Olendzki BC, et al. Dietary magnesium intake improves insulin resistance among non-diabetic individuals with metabolic syndrome participating in a dietary trial. Nutrients. 2013;5:3910-9.
Marathe PH, Gao HX, Close KL. American Diabetes Association Standards of Medical Care in Diabetes 2017. J Diabetes. 2017 Jan 10. doi: 10.1111/1753-0407.12524. [Epub ahead of print]
Diabetes Trials Unit: The Oxford Centre for Diabetes. HOMA Calculator. Endocrinology and Metabolism. Available from: http:// www.dtu.ox.ac.uk/homacalculator/index.php
McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24: 460-4.
Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care. 1999;22:1462-70.
Bastard J-P, Faraj M, Karelis AD, Lavasseur J, Garrel D, Prud’homme D, et al. Muscle and liver insulin resistance indexes derived from the oral glucose tolerance test. Diabetes Care 2007;30:e83; author reply e84.
G utch M, Kumar S, Razi SM, Gupta KK, Gupta A. Assessment of insulin sensitivity/resistance. Indian J Endocrinol Metab. 2015; 19:160-4.
Muñoz de Chávez M, Ledesma Solano JA. Composición de alimentos : valor nutritivo de los alimentos de mayor consumo. McGraw-Hill; 2010.
Scheen AJ. Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? Diabetes Metab. 2005;2: 5S27-34.
G eer EB, Shen W. Gender differences in insulin resistance, body composition, and energy balance. Gend Med. 2009;6:60-75.
G uerrero-Romero F, Tamez-Perez H, González-González G, et al. Oral Magnesium supplementation improves insulin sensitivity in non-diabetic subjects. Diabetes Metab. 2004;253: 253-8.
G uerrero-Romero F, Rodríguez-Morán M. Complementary therapies for diabetes: The case for chromium, magnesium, and antioxidants. Arch Med Res. 2005;36:250-7.
G uerrero-Romero F, Rodríguez-Morán M. Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: double-blind, randomized clinical trial. Eur J Clin Invest. 2011;41:405-10.
Hadjistavri LS, Sarafidis PA, Georgianos PI, et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit. 2010;16:CR307-12.
Simental-Mendía LE, Sahebkar A, Rodríguez-Morán M, Guerrero- Romero F. A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control. Pharmacol Res. 2016;111:272-82.
E lin RJ. Assessment of magnesium status. Clin Chem 1987;33: 1965-70.
Djurhuus MS, Gram J, Petersen PH, Klitgaard NA, Bollerslev J, Beck-Nielsen H. Biological variation of serum and urinary magnesium in apparently healthy males. Scand J Clin Lab Invest. 1995;55:549-58.
Song C, Choi W, Oh H, Kim K. Associations of serum minerals with body mass index in adult women. Eur J Clin Nutr. 2007; 61:682-5.
Rodríguez-Hernández H, Gonzalez JL, Rodríguez-Morán M, Guerrero- Romero F. Hypomagnesemia, insulin resistance, and nonalcoholic steatohepatitis in obese subjects. Arch Med Res. 2016; 36:362-6.
Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance. The role of intracellular magnesium. Am J Hypertens. 1997;10:346-55.
Willett W. Food-Frequency Methods. In: Nutritional Epidemiology. Oxford University Press; 1998 p. 74-100. Available from: http://www.oxfordscholarship.com/view/10.1093/acprof:o so/9780195122978.001.0001/acprof-9780195122978- chapter-05 [Accessed 2016 Oct 3].